Susan Estes
Adult Health · Aurora, CONPI 1497842546
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,052 of the $5,037 with a category attached, or 80.4%. 15 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 51.4% of the total. 2025 is the largest year on record at $2,550, 4.9 times the $520 reported in 2022. Among adult health clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $51.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Boston Scientific$1K
- AbbVie$423
- Abbott$140
- Vertos Medical, Inc.$127
- SPR Therapeutics, Inc$126
- plus $502 from 9 others
What the payments were for
- Travel & lodging$98620%
- Food & beverage$4,05280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 29 | $2,589 |
| Boston Scientific | 21 | $1,131 |
| AbbVie(2 entities) | 18 | $423 |
| Abbott | 1 | $140 |
| Vertos Medical, Inc. | 1 | $127 |
| SPR Therapeutics, Inc | 6 | $126 |
| Nalu Medical, Inc. | 2 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $87 |
| Bioventus LLC | 4 | $78 |
| GRT US Holding, Inc. | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 4 | $57 |
| Medtronic | 2 | $44 |
| Histosonics, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$1,810
- WaveWriter Alpha Prime 16$381
- Evoke SCS$161
- ETERNA$140
- mild Device Kit$127
- QULIPTA$105
- Nalu Neurostimulation System$101
How this compares
$5,037 in reported general payments places this provider in the 90th percentile of 430 adult health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 11 | $46,431 |
| OxycontinOxycodone Hcl | 82 | $39,964 |
| Xtampza ErOxycodone Myristate | 65 | $39,667 |
| Buprenorphine | 140 | $37,646 |
| Nucynta ErTapentadol Hcl | 20 | $32,968 |
| BelbucaBuprenorphine Hcl | 30 | $24,978 |
| MovantikNaloxegol Oxalate | 24 | $17,993 |
| Hysingla ErHydrocodone Bitartrate | 27 | $17,508 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 410 | $13,305 |
| Oxycodone Hcl | 518 | $10,089 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $9,806 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 37 | $9,027 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 256 | $9,010 |
| Morphine Sulfate ErMorphine Sulfate | 325 | $8,622 |
| Gabapentin | 342 | $5,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca | $57 | $97,613115 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $87 | $46,43111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 430 adult health providers in Colorado.
Other adult health in Aurora
- Stefanie EymarAurora$36K
- Alexandra GravesAurora$18K
- Keri HalsemaAurora$17K
- Grace WorlandAurora$11K
- Glen PetersonAurora$8K
- Amber KohlerAurora$6K
- Kimberly NdahayoAurora$5K
- Aparna GuptaAurora$5K
- Ann PereiraAurora$5K
- Jennifer HuttonAurora$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.